JPH0689025B2 - Method for recovering water-soluble protein from egg yolk - Google Patents

Method for recovering water-soluble protein from egg yolk

Info

Publication number
JPH0689025B2
JPH0689025B2 JP716389A JP716389A JPH0689025B2 JP H0689025 B2 JPH0689025 B2 JP H0689025B2 JP 716389 A JP716389 A JP 716389A JP 716389 A JP716389 A JP 716389A JP H0689025 B2 JPH0689025 B2 JP H0689025B2
Authority
JP
Japan
Prior art keywords
water
egg yolk
soluble protein
soluble
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP716389A
Other languages
Japanese (ja)
Other versions
JPH02188533A (en
Inventor
豊 池森
Original Assignee
株式会社ゲン・コーポレーション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社ゲン・コーポレーション filed Critical 株式会社ゲン・コーポレーション
Priority to JP716389A priority Critical patent/JPH0689025B2/en
Publication of JPH02188533A publication Critical patent/JPH02188533A/en
Publication of JPH0689025B2 publication Critical patent/JPH0689025B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は卵黄からの水溶性タンパク質の回収方法に係
り、特に免疫鶏卵からIgG抗体、IgM抗体等の水溶性タン
パク質を回収するのに適した卵黄からの水溶性タンパク
質の回収方法に関するものである。
TECHNICAL FIELD The present invention relates to a method for recovering a water-soluble protein from egg yolk, and is particularly suitable for recovering a water-soluble protein such as an IgG antibody and an IgM antibody from an immunized chicken egg. The present invention relates to a method for recovering a water-soluble protein from egg yolk.

[従来の技術] 近年、免疫鶏卵を用いる特異的抗体の生成が可能とな
り、従来の血液抗体に代わって鶏卵抗体を用いる受動免
疫の可能性が高まってきている。鶏の血清抗体IgG、IgM
は卵黄を介して子孫へ移行し、これらの抗体は卵黄の水
溶性タンパク質画分に存在する。そのため、抗体の生理
活性を有効に利用するためには、卵黄の水溶性タンパク
質と卵黄リポタンパク質との分画回収が必要となる。
[Prior Art] In recent years, it has become possible to generate specific antibodies using immunized chicken eggs, and the possibility of passive immunization using chicken egg antibodies instead of conventional blood antibodies is increasing. Chicken serum antibody IgG, IgM
Translocate to the offspring via the yolk, and these antibodies are present in the water-soluble protein fraction of the yolk. Therefore, in order to effectively utilize the physiological activity of the antibody, it is necessary to collect fractions of the yolk water-soluble protein and the yolk lipoprotein.

従来、卵黄から水溶性タンパク質を回収する方法とし
て、卵黄をクロロホルムで抽出して残りの溶液を得る方
法(T.T.Kramer et al.1970 Immunology 19,157;R.E.Fa
ith et al.1973 Immunology 25,151)や、卵黄液にポリ
エチレングリコールを添加して卵黄リポタンパク質を沈
澱分離させて上清から水溶性タンパク質を得る方法があ
る。又、卵黄の水溶性タンパク質と卵黄リポタンパク質
との分離精製方法として卵黄液にカラギナンやキサンタ
ンガムを加えて卵黄リポタンパク質を沈澱させ、上清か
ら水溶性タンパク質を得る方法が八田らにより提案され
ている(日本農芸化学会誌、62巻3号(昭和63年度大会
講演要旨集第4ページ2Aa15))。
Conventionally, as a method of recovering a water-soluble protein from egg yolk, a method of extracting the egg yolk with chloroform to obtain the remaining solution (TTKramer et al. 1970 Immunology 19,157; REFa
ith et al. 1973 Immunology 25, 151) or a method in which polyethylene glycol is added to egg yolk liquid to separate the egg yolk lipoprotein by precipitation to obtain a water-soluble protein from the supernatant. Also, as a method for separating and purifying egg yolk water-soluble protein and egg yolk lipoprotein, a method has been proposed by Hatta et al. (Journal of the Japanese Society of Agricultural Chemistry, Vol. 62, No. 3 (Abstracts of 1988 Conference, 4th page, 2Aa15)).

[発明が解決しようとする課題] ところが、クロロホルムで卵黄リポタンパク質を抽出す
る方法は水溶性タンパク質の回収率が悪いだけでなく、
クロロホルムが生体に有害なため回収した水溶性タンパ
ク質である抗体を生体に使用するためにはクロロホルム
の完全な除去が必要となり、精製が面倒となる不都合が
ある。又、カラギナンを加える方法も水溶性タンパク質
の回収率が悪く、抗体価が低下するという問題がある。
さらに、カラギナンについては腫瘍性大腸炎の誘因物質
であるとの報告(James L.Breeling,et al.INFECTION A
ND IMMUNITY Vol.56,No.7 1988.p.1754〜1759,Onderdon
k,A.B.,et al 1983.Enhancement of experimental ulce
rative colitis by immunization with Bacterides vul
gatus.Infect.Immun.42:783−788.)もある。
[Problems to be Solved by the Invention] However, the method of extracting egg yolk lipoprotein with chloroform not only has a poor recovery rate of water-soluble proteins,
Since chloroform is harmful to the living body, it is necessary to completely remove the chloroform in order to use the recovered antibody, which is a water-soluble protein, in the living body, which is inconvenient for purification. Further, the method of adding carrageenan also has a problem that the recovery rate of water-soluble protein is poor and the antibody titer is lowered.
Furthermore, carrageenan is reported to be an inducer of neoplastic colitis (James L. Breeling, et al. INFECTION A
ND IMMUNITY Vol.56, No.7 1988.p.1754 ~ 1759, Onderdon
k, AB, et al 1983.Enhancement of experimental ulce
rative colitis by immunization with Bacterides vul
gatus.Infect.Immun.42: 783-788.).

又、卵黄から分離した水溶性タンパク質としての抗体の
保存、取扱いを容易にするため、水溶性タンパク質を乾
燥した固体にすることが好ましい。ポリエチレングリコ
ールを使用する方法は水溶性タンパク質の回収率は良い
が、回収した上清にはポリエチレングリコールが含まれ
ているため、その乾燥が難しいという問題がある。
Further, in order to facilitate storage and handling of the antibody as a water-soluble protein separated from egg yolk, it is preferable to make the water-soluble protein a dry solid. The method using polyethylene glycol has a good recovery rate of the water-soluble protein, but since the recovered supernatant contains polyethylene glycol, there is a problem that it is difficult to dry it.

本発明は前記の問題点に鑑みてなされたものであって、
その目的は卵黄から水溶性タンパク質である抗体を、抗
体価を低下させることなく卵黄リポタンパク質と分離し
て効率よく回収することができるとともに、回収後の乾
燥も容易な卵黄からの水溶性タンパク質の回収方法を提
供することにある。
The present invention has been made in view of the above problems,
The purpose is to separate the antibody, which is a water-soluble protein from egg yolk, by separating it from the egg yolk lipoprotein without lowering the antibody titer, and to collect it efficiently after drying. It is to provide a recovery method.

[課題を解決するための手段及び作用] 前記の目的を達成するため第1請求項に記載の発明にお
いては、卵黄液に水溶性のセルロース誘導体,ポリビニ
ルアルコールあるいはシクロデキストリンの内より選ば
れた物質の1種以上を含む水溶液を加えて混合し、その
上清を回収するという方法を採用した。
[Means and Actions for Solving the Problems] In order to achieve the above object, in the invention according to claim 1, a substance selected from a water-soluble cellulose derivative, polyvinyl alcohol, and cyclodextrin in egg yolk liquid. An aqueous solution containing at least one of the above was added and mixed, and the supernatant was collected.

卵黄液とは割卵後に卵白液と分離された生卵黄液だけで
なく、それを水で希釈した溶液をも含み、卵黄は鶏だけ
でなくアヒル等他の家禽の卵から調整されたものでもよ
い。
Egg yolk liquid includes not only raw yolk liquid separated from egg white liquid after breaking eggs, but also a solution diluted with water, and yolk prepared not only from chicken but also from other poultry eggs such as ducks. Good.

水溶性セルロース誘導体としてはメチルセルロース、ヒ
ドロキシプロピルセルロース(HPC)、ヒドロキシプロ
ピルメチルセルロース(HPMC)が好ましい。卵黄液に加
える水溶性物質の量は、水溶液を全量添加後の最終溶液
中の水溶性物質の濃度が0.1〜数パーセントの範囲であ
ればよい。水溶性物質は単独で使用するのが取扱いの点
から好ましいが、複数種を混合して使用してもよい。
又、水溶性物質は水溶液の状態で卵黄液に加えるが、そ
の濃度は水溶液添加後の最終濃度が前記の範囲であれば
よいが、取扱い易さの点から、溶液の粘度が大きくなら
ない1〜3%の濃度が好ましい。卵黄液も生の卵黄液を
そのまま使用するよりも取扱い易さの点から、水で2〜
5倍に希釈したほうがよい。
As the water-soluble cellulose derivative, methyl cellulose, hydroxypropyl cellulose (HPC) and hydroxypropyl methyl cellulose (HPMC) are preferable. The amount of the water-soluble substance added to the yolk liquid may be in the range of 0.1 to several percent such that the concentration of the water-soluble substance in the final solution after the total amount of the aqueous solution has been added. It is preferable to use the water-soluble substance alone from the viewpoint of handling, but a plurality of types may be mixed and used.
Further, the water-soluble substance is added to the yolk liquid in the state of an aqueous solution, and the concentration thereof may be within the above-mentioned final concentration after the addition of the aqueous solution, but from the viewpoint of easy handling, the viscosity of the solution does not increase 1 to A concentration of 3% is preferred. Egg yolk can be treated with water 2 to 3 times because it is easier to handle than using raw yolk liquid as it is.
It is better to dilute 5 times.

卵黄液に前記水溶性物質の適量濃度の溶液を加えたて攪
拌した後、放置すると卵黄リポタンパク質が沈殿として
水溶性タンパク質から分離される。卵黄リポタンパク質
沈殿の分離は、一般的には遠心分離により行われるが、
卵黄処理液の濃度が低い場合にはそのままの状態での
過、過助剤を加えた状態での過あるいはデカンテー
ションによっても分離が可能である。
After adding a solution of the water-soluble substance in an appropriate concentration to the yolk liquid and stirring the mixture, the yolk lipoprotein is separated from the water-soluble protein as a precipitate when left to stand. Separation of egg yolk lipoprotein precipitate is generally performed by centrifugation,
When the concentration of the egg yolk treatment liquid is low, the separation can be carried out as it is, by adding a super-auxiliary agent or by decantation.

得られた上清をそのままの状態で使用時まで保存しても
よいが、保存、取扱いを容易にするため適宜の方法で乾
燥して固体状態で保存するのが好ましい。
The obtained supernatant may be stored as it is until use, but it is preferable to dry it by an appropriate method and store it in a solid state in order to facilitate storage and handling.

又、第2請求項記載の発明では、卵黄液にメタアクリル
酸とアクリル酸エチル又はメタアクリル酸メチルの共重
合体あるいはヒドロキシプロピルメチルセルロースフタ
レート等pH5.0〜6.0よりアルカリ性寄りで溶解する高分
子物質を不均一状態で接触させた後、その上清を回収す
るようにした。
Further, in the second aspect of the present invention, a polymer substance which dissolves in egg yolk liquid with a copolymer of methacrylic acid and ethyl acrylate or methyl methacrylate or hydroxypropylmethyl cellulose phthalate such that it is more alkaline than pH 5.0 to 6.0. Were contacted in a non-uniform state, and the supernatant was then collected.

メタアクリル酸とアクリル酸エチルの共重合体は中性の
水に不溶であるがpH5.5で溶解し、アルコールには可溶
でアルコール溶液を水に加えることによりエマルジョン
となる。メタアクリル酸とメアクリル酸メチルの共重合
体は中性の水に不溶であるがpH6.0以上で溶解し、又、
アルコールには溶解するがアルコール溶液を水に加えて
もエマルジョンを得ることはできない。ヒドロキシプロ
ピルメチルセルロースフタレートはアルコールには溶解
するがアルコール溶液を水に加えてもエマルジョンを得
ることはできない。すなわち、第2請求項記載の発明で
は高分子物質は不均一状態で卵黄液と接触する。
The copolymer of methacrylic acid and ethyl acrylate is insoluble in neutral water, but is soluble at pH 5.5, soluble in alcohol and becomes an emulsion by adding an alcohol solution to water. The copolymer of methacrylic acid and methyl methacrylate is insoluble in neutral water but soluble at pH 6.0 or above,
It dissolves in alcohol, but an emulsion cannot be obtained by adding an alcohol solution to water. Hydroxypropylmethylcellulose phthalate dissolves in alcohol, but an emulsion cannot be obtained even if an alcohol solution is added to water. That is, in the invention according to the second aspect, the polymer substance comes into contact with the yolk liquid in a non-uniform state.

アルコール溶液からエマルジョンを得ることができない
高分子物質の場合には、卵黄液(水で希釈した物)にア
ルコール溶液(濃度数パーセント)を加えることにより
卵黄液との接触が行われ、加える量は添加後の溶液に対
して0.05〜0.3%となる量が好ましい。アルコール溶液
は卵黄液に一度に加えてもよいが、少量ずつ滴下するほ
うがよい。又、エマルジョンで加える場合には前記水溶
液の場合と同様な操作でよい。
In the case of a high molecular weight substance that cannot obtain an emulsion from an alcohol solution, it is contacted with the yolk liquid by adding the alcohol solution (concentration several percent) to the yolk liquid (diluted with water). The amount is preferably 0.05 to 0.3% with respect to the solution after addition. The alcohol solution may be added to the yolk liquid all at once, but it is better to add it little by little. When the emulsion is added, the same operation as in the case of the aqueous solution may be performed.

[実施例] 以下、本発明についてより具体的に説明する。[Examples] Hereinafter, the present invention will be described more specifically.

(免疫鶏卵の採取方法) 繊毛型毒素原性大腸菌(ブタの下痢由来大腸菌)の987
p、k88及びk99をそれぞれミンカ液体培地を使用して37
℃で定法により培養後、遠心により菌体を集め、集めた
菌体をホモジナイザにかけて繊毛を分離した。得られた
繊毛を適宜のアジュバンドと混合して鶏に筋肉注射し、
1回目の免疫を行った後、6週間後に2回目の免疫を1
回目と同様に行った。この鶏が生んだ卵を免疫鶏卵とし
て使用した。
(Collecting method of immunized chicken egg) Cilia-type toxigenic Escherichia coli (porcine diarrhea-derived Escherichia coli) 987
p, k88 and k99 respectively using Minka liquid medium 37
After culturing at ℃ by the standard method, the bacterial cells were collected by centrifugation, and the collected bacterial cells were subjected to a homogenizer to separate cilia. Mix the obtained cilia with an appropriate adjuvant and intramuscularly inject the chicken,
6 weeks after the first immunization, the second immunization 1
It went like the first time. The eggs laid by this chicken were used as immune chicken eggs.

又、ロタウィルス(牛の下痢由来シマネ株)をMA−104
細胞に接触し、定法により培養した。培養液からロタウ
ィルスを限外過により精製、濃縮後、適宜のアジュバ
ンドと混合して鶏に筋肉注射し、1回目の免疫を行った
後、4週間後に2回目の免疫を1回目と同様に行った。
この鶏が生んだ卵を免疫鶏卵として使用した。
Also, rotavirus (Shimane strain from bovine diarrhea) was added to MA-104
The cells were contacted and cultured by a standard method. The rotavirus was purified from the culture solution by ultrafiltration, concentrated, mixed with an appropriate adjuvant, intramuscularly injected into a chicken, and the first immunization was performed. Four weeks later, the second immunization was the same as the first immunization. Went to.
The eggs laid by this chicken were used as immune chicken eggs.

(卵黄からの水溶性タンパク質の回収方法) .水溶性物質を使用した場合。(Method for recovering water-soluble protein from egg yolk). When using water-soluble substances.

免疫鶏卵から卵黄を分離し、水を加えて2.5倍に希釈し
て卵黄液とした。この卵黄液10mlにセルロース誘導体,
ポリビニールアルコールあるいはシクロデキストリンを
所定濃度に溶解した水溶液を10ml加え、室温(25℃)で
攪拌後30分間放置した。この溶液を5000gで20分遠心し
た後、上清を得た。
Egg yolk was separated from the immunized chicken egg, and water was added to dilute the yolk 2.5 times to obtain yolk liquid. Cellulose derivative,
10 ml of an aqueous solution in which polyvinyl alcohol or cyclodextrin was dissolved at a predetermined concentration was added, and the mixture was stirred at room temperature (25 ° C) and left for 30 minutes. This solution was centrifuged at 5000 g for 20 minutes, and a supernatant was obtained.

.メタアクリル酸とアクリル酸エチルの共重合体を使
用した場合。
. When using a copolymer of methacrylic acid and ethyl acrylate.

メタアクリル酸とアクリル酸エチルの共重合体(オイド
ラギットL30D(Rhm Pharma社製))に水を加えて所
定濃度のエマルジョンとした。このエマルジョン10mlを
前記と同様にして得た卵黄液10mlに加え、室温(25℃)
で攪拌後30分間放置した。この溶液を5000gで20分遠心
した後、上清を得た。
Water was added to a copolymer of methacrylic acid and ethyl acrylate (Eudragit L30D (manufactured by Rhm Pharma)) to prepare an emulsion having a predetermined concentration. Add 10 ml of this emulsion to 10 ml of yolk liquid obtained in the same manner as above, and add at room temperature (25 ° C).
After stirring for 30 minutes, the mixture was left for 30 minutes. This solution was centrifuged at 5000 g for 20 minutes, and a supernatant was obtained.

水に不溶の物質を使用した場合 メタアクリル酸とメタアクリル酸メチルの共重合体(オ
イドラギットL100(Rhm Pharma社製))を5%の濃
度でアルコールに溶解した。前記と同様にして得た2.5
倍希釈の卵黄液10mlに水を加えて全量をほぼ2mlとした
溶液に、前記共重合体のアルコール溶液を攪拌しながら
所定量滴下した。前記2.5倍希釈の卵黄液に加える水の
量はアルコール溶液の滴下量との合計が10mlとなるよう
に調整した。この溶液を5000gで20分遠心した後、上清
を得た。
When a substance insoluble in water was used A copolymer of methacrylic acid and methyl methacrylate (Eudragit L100 (manufactured by Rhm Pharma)) was dissolved in alcohol at a concentration of 5%. 2.5 as obtained above
A predetermined amount of the alcohol solution of the copolymer was added dropwise to a solution in which 10 ml of the double-diluted egg yolk solution was added with water to make the total amount approximately 2 ml. The amount of water added to the 2.5-fold diluted yolk liquid was adjusted so that the total amount with the amount of the alcohol solution added was 10 ml. This solution was centrifuged at 5000 g for 20 minutes, and a supernatant was obtained.

ヒドロキシプロピルメチルセルロースフタレートHPMC
P)を5%の濃度でアルコールに溶解した。前記と同様
にして得た2.5倍希釈の卵黄液10mlに水を加えて全量を
ほぼ20mlとした溶液に、前記共重合体のアルコール溶液
を攪拌しながら所定量滴下した。前記2.5倍希釈の卵黄
液に加える水の量はアルコール溶液の滴下量との合計が
10mlとなるように調整した。この溶液を5000gで20分遠
心した後、上清を得た。
Hydroxypropyl methylcellulose phthalate HPMC
P) was dissolved in alcohol at a concentration of 5%. A predetermined amount of the alcohol solution of the copolymer was added dropwise to 10 ml of the 2.5-fold diluted egg yolk liquid obtained in the same manner as described above with water to make the total amount approximately 20 ml. The amount of water added to the 2.5-fold diluted yolk liquid is the sum of the amount of alcohol solution added dropwise.
It was adjusted to 10 ml. This solution was centrifuged at 5000 g for 20 minutes, and a supernatant was obtained.

(抗体価の測定) 大腸菌に対する抗体価の測定は定法に従い凝集試験で
行った。
(Measurement of antibody titer) The antibody titer against E. coli was measured by an agglutination test according to a standard method.

ロタウィルスに対する抗体価の測定は定法に従い、中
和試験で行った。
The antibody titer against rotavirus was measured by a neutralization test according to a standard method.

上記の方法に従って各種の大腸菌あるいはロタウィルス
に対する免疫鶏卵の卵黄からの水溶性タンパク質の回収
試験及び回収上清の抗体価の測定を行った結果を表に示
す。なお、表中の濃度は卵黄液に各溶液を全量添加後の
溶液に対する各添加物質の濃度を、又、回収量は遠心後
に得られた上清の量を表している。
The table below shows the results of a test for collecting water-soluble proteins from egg yolk of chicken eggs that were immunized against various Escherichia coli or rotaviruses according to the above-described method, and the antibody titer of the collected supernatant was measured. The concentration in the table indicates the concentration of each added substance relative to the solution after the total amount of each solution was added to the yolk liquid, and the recovered amount indicates the amount of the supernatant obtained after centrifugation.

比較例として卵黄液を等量のクロロホルムで処理した
後、等量のカラギナン水溶液で処理したもの及び全卵に
ついての試験結果を合わせて示す。
As a comparative example, the test results of the egg yolk liquid treated with an equal amount of chloroform and then treated with an equal amount of an aqueous solution of carrageenan and the test results of whole eggs are also shown.

表から明らかなように比較例の従来方法では、上清の回
収量がクロロホルム処理の場合が7mlで、カラギナン水
溶液処理の場合が5.5mlと少ないのに対して、水溶性物
質を使用した本発明の回収方法では回収量はいずれの場
合にも17mlと多く、クロロホルム処理の約2.4倍、カラ
ギナン水溶液処理の約3倍の上清を得ることができた。
又、中性の水に溶解しない物質を使用した場合は、水溶
性物質を使用した場合に比較して上清の回収量は若干悪
くなるが、従来の方法に比較して2倍近くの上清が得ら
れた。
As is clear from the table, in the conventional method of Comparative Example, the recovered amount of the supernatant was 7 ml in the case of the chloroform treatment and 5.5 ml in the case of the carrageenan aqueous solution treatment, which was as small as 5.5 ml. In any of the above collection methods, the collected amount was as large as 17 ml, and it was possible to obtain a supernatant of about 2.4 times that of the chloroform treatment and about 3 times that of the carrageenan aqueous solution treatment.
Also, when a substance that does not dissolve in neutral water is used, the amount of supernatant recovered is slightly worse than when a water-soluble substance is used, but it is almost twice as high as that of the conventional method. Qing was obtained.

得られた上清の抗体価は、比較例のクロロホルム処理の
場合には大腸菌の877pを除き、いずれの免疫抗原に対し
ても全卵のものと同等であったが、カラギナン水溶液処
理の場合には全ての免疫抗原に対して全卵のものより低
下した。一方、水溶性物質を使用した本発明の場合には
ポリビニルアルコール1.5%で処理した場合の大腸菌の9
87pを除き、いずれの免疫抗原に対しても全卵のものと
同等であった。又、中性の水に溶解しない物質を使用し
た場合には、大腸菌の987p以外の免疫抗原に対しては全
卵のものと同等で、大腸菌の987pに対してはヒドロキシ
プロピルメチルセルロースフタレートの場合及びメタア
クリル酸とアクリル酸エチルの共重合体のエマルジョン
(濃度0.25%溶液)を使用した場合は全卵のものと同等
であったが、その他の場合は従来方法の場合と同程度に
低下した。
The antibody titer of the obtained supernatant was the same as that of whole egg against any immunoantigen except for 877p of Escherichia coli in the case of the chloroform treatment of the comparative example, but in the case of the carrageenan aqueous solution treatment. Was lower than that of whole egg for all immune antigens. On the other hand, in the case of the present invention using a water-soluble substance, 9% of E. coli treated with 1.5% polyvinyl alcohol was used.
Except for 87p, it was equivalent to that of whole egg against all immunogens. Also, when a substance that does not dissolve in neutral water is used, it is equivalent to whole egg against immune antigens other than 987p of E. coli, and hydroxypropylmethylcellulose phthalate against 987p of E. coli. When an emulsion of a copolymer of methacrylic acid and ethyl acrylate (solution with a concentration of 0.25%) was used, it was equivalent to that of whole eggs, but in other cases, it decreased to the same extent as in the case of the conventional method.

なお、得られた上清は取扱い、保存を容易とするため適
宜の方法で乾燥され、水溶性タンパク質は固体状態で保
存されるが、上清を乾燥せずに水溶液のままあるいは濃
縮して保存してもよい。水溶性物質を使用した場合には
上清中にも水溶性物質が多く溶解しているので、乾燥に
より得られた固体状態の水溶性タンパク質には水溶性物
質が混じっているが、本発明で使用される水溶性物質は
いずれも生体内への投与が認められている物質であるた
め支障はない。
The resulting supernatant is dried by an appropriate method to facilitate handling and storage, and the water-soluble protein is stored in a solid state, but the supernatant is not dried but stored as an aqueous solution or concentrated. You may. When a water-soluble substance is used, a large amount of the water-soluble substance is also dissolved in the supernatant. Therefore, the solid-state water-soluble protein obtained by drying contains the water-soluble substance. All the water-soluble substances used are substances that have been approved for in vivo administration, so there is no problem.

又、本発明を抗体以外の水溶性タンパク質の回収に適用
してもよい。
The present invention may also be applied to the recovery of water-soluble proteins other than antibodies.

[発明の効果] 以上詳述したように本発明によれば、卵黄から水溶性タ
ンパク質である抗体を、抗体価をほとんど低下させるこ
となく卵黄リポタンパク質と分離して効率よく回収する
ことができ、しかも、回収した水溶液から乾燥した固体
状態の水溶性タンパク質を容易に得ることができる。
[Effects of the Invention] As described in detail above, according to the present invention, an antibody which is a water-soluble protein can be efficiently separated from egg yolk by separating it from egg yolk lipoprotein with almost no decrease in antibody titer, Moreover, the dried solid-state water-soluble protein can be easily obtained from the recovered aqueous solution.

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】卵黄液に水溶性のセルロース誘導体,ポリ
ビニールアルコールあるいはシクロデキストリンの内よ
り選ばれた物質の1種以上を含む水溶液を加えて混合
し、その上清を回収することを特徴とする卵黄からの水
溶性タンパク質の回収方法。
1. An egg yolk solution is mixed with an aqueous solution containing at least one substance selected from water-soluble cellulose derivatives, polyvinyl alcohol and cyclodextrin, and the mixture is recovered. A method for recovering a water-soluble protein from egg yolk.
【請求項2】卵黄液にメタアクリル酸とアクリル酸エチ
ル又はメタアクリル酸メチルの共重合体あるいはヒドロ
キシプロピルメチルセルロースフタレート等pH5.0〜6.0
よりアルカリ性寄りで溶解する高分子物質を不均一状態
で接触させた後、その上清を回収することを特徴とする
卵黄からの水溶性タンパク質の回収方法。
2. A copolymer of methacrylic acid and ethyl acrylate or methyl methacrylate, hydroxypropylmethyl cellulose phthalate, etc. in egg yolk liquid, pH 5.0 to 6.0.
A method for recovering a water-soluble protein from egg yolk, which comprises contacting a high-molecular substance which is more alkaline and contacting it in a heterogeneous state, and recovering the supernatant.
JP716389A 1989-01-14 1989-01-14 Method for recovering water-soluble protein from egg yolk Expired - Fee Related JPH0689025B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP716389A JPH0689025B2 (en) 1989-01-14 1989-01-14 Method for recovering water-soluble protein from egg yolk

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP716389A JPH0689025B2 (en) 1989-01-14 1989-01-14 Method for recovering water-soluble protein from egg yolk

Publications (2)

Publication Number Publication Date
JPH02188533A JPH02188533A (en) 1990-07-24
JPH0689025B2 true JPH0689025B2 (en) 1994-11-09

Family

ID=11658412

Family Applications (1)

Application Number Title Priority Date Filing Date
JP716389A Expired - Fee Related JPH0689025B2 (en) 1989-01-14 1989-01-14 Method for recovering water-soluble protein from egg yolk

Country Status (1)

Country Link
JP (1) JPH0689025B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02011761A (en) * 2002-10-30 2004-06-03 Invest Aplic S A De C V Prevention and treatment of the respiratory and reproductive syndrome of pig (prrs) with the use of immunoglobulins obtained from the yolk of an egg of hyperimmunized hens with the virus of prrs.
JP4980942B2 (en) * 2008-02-07 2012-07-18 江崎グリコ株式会社 Production method of egg yolk protein

Also Published As

Publication number Publication date
JPH02188533A (en) 1990-07-24

Similar Documents

Publication Publication Date Title
Lawrence Homograft sensitivity: an expression of the immunologic origins and consequences of individuality
US5420253A (en) Method for purifying egg yolk immunoglobulins
US4816253A (en) Novel mutant strain of Listeria monocytogenes and its use in production of IgM antibodies and as an immunotherapeutic agent
Fuda et al. A peculiar immunoglobulin M (IgM) identified in eggs of chum salmon (Oncorhynchus keta)
CN1062605C (en) Escherichia coli vaccine
US4567041A (en) Mutant strain of Listeria monocytogenes and its use in production of IgM antibodies and as an immunotherapeutic agent
US4157390A (en) Process for vaccine preparation
Parry et al. Immunological aspects of cell membrane adhesion demonstrated by porcine enteropathogenic Escherichia coli
Guentzel et al. Use of fluorescent antibody in studies of immunity to cholera in infant mice
KR20150080643A (en) Ipv-dpt vaccine
EP0211001B1 (en) Liver fluke antigens
Coeurdacier et al. Alterations in total protein, IgM and specific antibody activity of male and female sea bass (Dicentrarchus labraxL., 1758) sera following injection with killedVibrio anguillarum
JPS6053009B2 (en) A new drug for the treatment of acute or chronic infections caused by hepatitis virus B
JPH0689025B2 (en) Method for recovering water-soluble protein from egg yolk
Mason Smith et al. A BALB/c mouse IgA myeloma protein that binds Salmonella flagellar protein
JPH02138130A (en) Manufacture of polymerized allergen
Partridge et al. Immunization experiments with artificial complexes formed from substances isolated from the antigen of Bact. shigae
Loghothetis et al. Antibody responses of rainbow trout (Oncorhynchus mykiss, Walbaum) to liveAeromonas hydrophilaas assessed by various antigen preparations
Spooner et al. The isolation of ox red cell membrane antigens: antigens associated with sialoprotein
CA1061252A (en) Antigenic compositions
Gough The purification of tuberculin
CA2171317C (en) Method for purifying egg yolk immunoglobulins
GB2057451A (en) Immunological Preparations Comprising Egg Yolk Antibodies
Sakai Induction of nonspecific immunosuppression in a primitive teleost, rainbow trout (Salmogairdneri)
US3629397A (en) Therapeutic and diagnostic allergenic extracts and process for preparing same

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees